Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Fang Fang, Zuowei Wang, Renrong Wu, Joseph R. Calabrese & Keming Gao. (2017) Is there a ‘weight neutral’ second-generation antipsychotic for bipolar disorder?. Expert Review of Neurotherapeutics 17:4, pages 407-418.
Read now
Read now
Marina Garriga, Isabella Pacchiarotti, Siegfried Kasper, Scott L. Zeller, Michael H. Allen, Gustavo Vázquez, Leonardo Baldaçara, Luis San, R. Hamish McAllister-Williams, Konstantinos N. Fountoulakis, Philippe Courtet, Dieter Naber, Esther W. Chan, Andrea Fagiolini, Hans Jürgen Möller, Heinz Grunze, Pierre Michel Llorca, Richard L. Jaffe, Lakshmi N. Yatham, Diego Hidalgo-Mazzei, Marc Passamar, Thomas Messer, Miquel Bernardo & Eduard Vieta. (2016) Assessment and management of agitation in psychiatry: Expert consensus. The World Journal of Biological Psychiatry 17:2, pages 86-128.
Read now
Read now
Ludovic Samalin, Aurore Tremey & Pierre-Michel Llorca. (2014) Quetiapine extended release for the treatment of bipolar disorder. Expert Review of Neurotherapeutics 14:9, pages 987-1005.
Read now
Read now
Richard Weisler & Roger S McIntyre. (2013) The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder. Expert Review of Neurotherapeutics 13:11, pages 1161-1182.
Read now
Read now
Richard Weisler, Roger S McIntyre & Michael Bauer. (2013) Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy. Expert Review of Neurotherapeutics 13:11, pages 1183-1200.
Read now
Read now
Ioannis Michopoulos, Christos Christodoulou, John Dervenoulas, Costas R. Soldatos & Lefteris Lykouras. (2010) Quetiapine monotherapy in bipolar I disorder: A 1-year stabilization in a woman having undergone bone marrow transplantation. The World Journal of Biological Psychiatry 11:2-2, pages 519-521.
Read now
Read now
Eduard Vieta & Jose Sanchez-Moreno. (2008) Acute and long-term treatment of mania. Dialogues in Clinical Neuroscience 10:2, pages 165-179.
Read now
Read now
Huafang Li, Cui Ma, Gang Wang, Xiaotong Zhu, Mengye Peng & Niufan Gu. (2008) Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. Current Medical Research and Opinion 24:1, pages 1-10.
Read now
Read now
Nobutaka Motohashi, Kunihiko Shioe, Jun Nakamura, Akihiko Ohshima, Kazuo Yamada, Hiroki Ozawa, Toshiyuki Someya, Yosuke Uchitomi & Teruhiko Higuchi. (2008) Revised psychopharmacological algorithms for the treatment of mood disorders in Japan. International Journal of Psychiatry in Clinical Practice 12:1, pages 11-18.
Read now
Read now
Michael Riedel, Norbert Müller, Martin Strassnig, Ilja Spellmann, Emanuel Severus & Hans-Jürgen Möller. (2007) Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychiatric Disease and Treatment 3:2, pages 219-235.
Read now
Read now
Rogier M Klok, Asmar FY Al Hadithy, Nathalie PJT van Schayk, Ad JJ Antonisse, Jaime J Caro, Jacobus RBJ Brouwers & Maarten J Postma. (2007) Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder. Expert Review of Pharmacoeconomics & Outcomes Research 7:5, pages 459-467.
Read now
Read now
Eduard Vieta & Adriane R. Rosa. (2007) Evolving trends in the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry 8:1, pages 4-11.
Read now
Read now
Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni & A Carlo Altamura. (2006) The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder. Neuropsychiatric Disease and Treatment 2:2, pages 139-148.
Read now
Read now
Philip B Mitchell & Gin S Malhi. (2006) Emerging drugs for bipolar disorder. Expert Opinion on Emerging Drugs 11:4, pages 621-634.
Read now
Read now
Michael Berk, Karen Hallam, Nellie Lucas, Linda Kader, Craig MacNeil, Melissa Hasty, Seetal Dodd, Gin Malhi & Philippe Conus. (2006) Health-related quality of life and functioning in bipolar disorder: the impact of pharmacotherapy. Expert Review of Pharmacoeconomics & Outcomes Research 6:5, pages 509-523.
Read now
Read now
Stefano Pini, Marianna Abelli & Giovanni B Cassano. (2006) The role of quetiapine in the treatment of bipolar disorder. Expert Opinion on Pharmacotherapy 7:7, pages 929-940.
Read now
Read now
Hani Raoul Khouzam & Fiza Singh. (2006) Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine. Expert Review of Neurotherapeutics 6:2, pages 131-144.
Read now
Read now
. (2005) Speaker Abstracts. International Journal of Psychiatry in Clinical Practice 9:4, pages 301-331.
Read now
Read now
Articles from other publishers (73)
Alessandro Cuomo, Alessandro Spiti, Marco Chioccioli, Despoina Koukouna, Arianna Goracci, Simone Bolognesi & Andrea Fagiolini. 2022. Recovery and Major Mental Disorders. Recovery and Major Mental Disorders
199
224
.
Xuejuan Zhang, Yongcheng Li, Zhengwei Huang, Yingtong Cui, Ziyu Zhao, Xiao Yue, Guanlin Wang, Ruifeng Liang, Ying Huang, Wen Tan & Chuanbin Wu. (2019) Development and pharmacokinetics evaluation of quetiapine fumarate sustained-release tablets based on hydrophilic matrix. Journal of Drug Delivery Science and Technology 54, pages 101322.
Crossref
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2019. Psychische Erkrankungen. Psychische Erkrankungen
363
444.e8
.
Willie Earley, Suresh Durgam, Kaifeng Lu, Adam Ruth, György Németh, István Laszlovszky & Lakshmi N. Yatham. (2018) Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder. Journal of Affective Disorders 226, pages 239-244.
Crossref
Crossref
Michael Berk, Rothanthi Daglas, Orwa Dandash, Murat Yücel, Lisa Henry, Karen Hallam, Craig Macneil, Melissa Hasty, Christos Pantelis, Brendan P. Murphy, Linda Kader, Saji Damodaran, Michael T. H. Wong, Philippe Conus, Aswin Ratheesh, Patrick D. McGorry & Sue M. Cotton. (2018)
Quetiapine
v.
lithium in the maintenance phase following a first episode of mania: Randomised controlled trial
. British Journal of Psychiatry 210:6, pages 413-421.
Crossref
Crossref
Konstantinos N. Fountoulakis, Lakshmi Yatham, Heinz Grunze, Eduard Vieta, Allan Young, Pierre Blier, Siegfried Kasper & Hans Jurgen Moeller. (2016) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. International Journal of Neuropsychopharmacology, pages pyw100.
Crossref
Crossref
A Ahmad, S Sheikh, T Shah, MS Reddy, BSV Prasad, KK Verma, BB Chandrakant, M Paithankar, P Kale, RV Solanki, R Patel, H Barkate & I Ahmad. (2016) Endoxifen, a New Treatment Option for Mania: A Double‐Blind, Active‐Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen. Clinical and Translational Science 9:5, pages 252-259.
Crossref
Crossref
Fang Fang, Hongwei Sun, Zuowei Wang, Ming Ren, Joseph R. Calabrese & Keming Gao. (2016) Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management. CNS Drugs 30:9, pages 845-867.
Crossref
Crossref
Keming Gao, Renrong Wu & Joseph R. Calabrese. 2016. Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy. Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy
213
242
.
Ardita Aliko, Andy Wolff, Colin Dawes, Doron Aframian, Gordon Proctor, Jörgen Ekström, Nagamani Narayana, Alessandro Villa, Ying Wai Sia, Revan Kumar Joshi, Richard McGowan, Siri Beier Jensen, A. Ross Kerr, Anne Marie Lynge Pedersen & Arjan Vissink. (2015) World Workshop on Oral Medicine VI: clinical implications of medication-induced salivary gland dysfunction. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 120:2, pages 185-206.
Crossref
Crossref
Isabella Pacchiarotti, Andrea Murru, Georgios D. Kotzalidis, C. Mar Bonnin, Lorenzo Mazzarini, Francesc Colom & Eduard Vieta. (2015) Hyperprolactinemia and medications for bipolar disorder: Systematic review of a neglected issue in clinical practice. European Neuropsychopharmacology 25:8, pages 1045-1059.
Crossref
Crossref
Ather Muneer. (2015) Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an Update. Clinical Psychopharmacology and Neuroscience 13:1, pages 25-35.
Crossref
Crossref
Keming Gao, David E. Kemp, Renrong Wu & Joseph R. Calabrese. 2015. Psychiatry. Psychiatry
2129
2158
.
Heinz Grunze, Eduardo Kotlik, Raquel Costa, Teresa Nunes, Amílcar Falcão, Luis Almeida & Patrício Soares-da-Silva. (2015) Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: Experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. Journal of Affective Disorders 174, pages 70-82.
Crossref
Crossref
Machaon Bonafede, Julie C Locklear, Peter Wahlqvist, Liberty Fajutrao, Johan Szamosi, Katy Pan & Hans Eriksson. (2015) Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania. Journal of Comparative Effectiveness Research 4:1, pages 51-59.
Crossref
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2015. Psychische Erkrankungen. Psychische Erkrankungen
413
498
.
Kostas N. FountoulakisKostas N. Fountoulakis. 2015. Bipolar Disorder. Bipolar Disorder
461
625
.
Robert L FindlingSanjeev PathakWillie R EarleySherry LiuMelissa P DelBello. (2014) Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology 24:6, pages 325-335.
Crossref
Crossref
Giovani Missio, Doris Hupfeld Moreno, Fernando Fernandes, Danielle Soares Bio, Márcio Gehardt Soeiro-de-Souza, Domingos Rodrigues dos SantosJrJr, Denise Petresco David, Luis Felipe Costa, Frederico Navas Demétrio & Ricardo Alberto Moreno. (2013) The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole. Trials 14:1.
Crossref
Crossref
Julie C. Locklear, Berhanu Alemayehu, Robert S. Brody, Soheil Chavoshi, Ozgur Tunceli, David Kern & Willie R. Earley. (2013) Treatment Patterns, HealthCare Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data. Clinical Therapeutics 35:12, pages 1923-1932.
Crossref
Crossref
Yasser Khazaal, Martin Preisig, Anne Chatton, Nadine Kaufmann, Romain Bilancioni & Chin B. Eap. (2012) Use of High Doses of Quetiapine in Bipolar Disorder Episodes are not Linked to High Activity of Cytochrome P4503A4 and/or Cytochrome P4502D6. Psychiatric Quarterly 84:3, pages 329-335.
Crossref
Crossref
Xin Xiong, Li Yang & Jingli Duan. (2013) Development and validation of a sensitive and robust LC?MS/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma. Clinica Chimica Acta 423, pages 69-74.
Crossref
Crossref
Eduard VietaEduard Vieta. 2013. Managing Bipolar Disorder in Clinical Practice. Managing Bipolar Disorder in Clinical Practice
109
133
.
Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller & Eduard Vieta. (2012) Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience 262:S1, pages 1-48.
Crossref
Crossref
Xiaohai Li & Michael D. Cameron. (2012) Potential Role of a Quetiapine Metabolite in Quetiapine-Induced Neutropenia and Agranulocytosis. Chemical Research in Toxicology 25:5, pages 1004-1011.
Crossref
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2012. Psychische Erkrankungen. Psychische Erkrankungen
421
512
.
Andrew J. Cutler, Catherine Datto, Arvid Nordenhem, Margaret Minkwitz, Larisa Acevedo & Denis Darko. (2011) Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial. Clinical Therapeutics 33:11, pages 1643-1658.
Crossref
Crossref
Thomas Elias Elanjithara, Sophia Frangou & Philip McGuire. (2018) Treatment of the early stages of bipolar disorder. Advances in Psychiatric Treatment 17:4, pages 283-291.
Crossref
Crossref
Mauricio Kunz, Svante Nyberg & Lakshmi N. Yatham. 2011. Bipolar Psychopharmacotherapy. Bipolar Psychopharmacotherapy
193
222
.
Thomas L. Schwartz & Stephen M. Stahl. (2011) Treatment Strategies for Dosing the Second Generation Antipsychotics. CNS Neuroscience & Therapeutics 17:2, pages 110-117.
Crossref
Crossref
Rif S. El-MallakhAhmed Z. ElmaadawiYonglin GaoKavita LohanoR. Jeannie Roberts. (2011) Current and Emerging Therapies for the Management of Bipolar Disorders. Journal of Central Nervous System Disease 3, pages JCNSD.S4441.
Crossref
Crossref
Mario A. Cristancho & Michael E. Thase. (2010) The role of quetiapine extended release in the treatment of bipolar depression. Advances in Therapy 27:11, pages 774-784.
Crossref
Crossref
Terence A. Ketter, John O. BrooksIIIIII, Jennifer C. Hoblyn, Anne A. Holland, Jennifer Y. Nam, Jenifer L. Culver, Wendy K. Marsh & Julie C. Bonner. (2010) Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting. Journal of Psychiatric Research 44:14, pages 921-929.
Crossref
Crossref
Paul E. KeckJr.Jr., Susan L. McElroy & John M. Hawkins. 2010. Bipolar Disorder. Bipolar Disorder
285
293
.
P. ShajahanM. Taylor. (2009) The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice. Journal of Psychopharmacology 24:4, pages 565-572.
Crossref
Crossref
E. VietaT. Ramey, D. Keller, PA English, AD Loebel & J. Miceli. (2008) Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. Journal of Psychopharmacology 24:4, pages 547-558.
Crossref
Crossref
Patricia C. Davis, Orlando Bravo, Mark Gehrke & Connie T. Azumaya. (2010) Development and validation of an LC?MS/MS method for the determination of quetiapine and four related metabolites in human plasma. Journal of Pharmaceutical and Biomedical Analysis 51:5, pages 1113-1119.
Crossref
Crossref
Terence A. Ketter, Ofer Agid, Shitij Kapur, Antony Loebel, Cynthia O. Siu & Steven J. Romano. (2010) Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission. Journal of Psychiatric Research 44:1, pages 8-14.
Crossref
Crossref
Eric Constant, Arlette Seghers, Enio Ranalli, Vincent Ryckmans, Phillippe Snauwaert, Marcel Parent & Guy Vandenhoven. (2014) Safety, tolerability and efficacy of a rapid dose escalation of quetiapine in bipolar I mania: the FATIMA study. Acta Neuropsychiatrica 21:3, pages 125-132.
Crossref
Crossref
Mauricio Tohen & Eduard Vieta. (2009) Antipsychotic agents in the treatment of bipolar mania. Bipolar Disorders 11, pages 45-54.
Crossref
Crossref
Carlos Figueroa, Martin Brecher, Jennifer E. Hamer-Maansson & Helen Winter. (2009) Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33:2, pages 199-204.
Crossref
Crossref
P.E. Keck, P.J. Orsulak, A.J. Cutler, R. Sanchez, A. Torbeyns, R.N. Marcus, R.D. McQuade & W.H. Carson. (2009) Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study. Journal of Affective Disorders 112:1-3, pages 36-49.
Crossref
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2009. Psychische Erkrankungen. Psychische Erkrankungen
491
592
.
Thomas Schläpfer, Waldemar Greil & Irmela von Stralendorff. 2009. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
199
221
.
Terence A. Ketter, John O. Brooks, Jennifer C. Hoblyn, Laurel M. Champion, Jennifer Y. Nam, Jenifer L. Culver, Wendy K. Marsh & Julie C. Bonner. (2008) Effectiveness of lamotrigine in bipolar disorder in a clinical setting. Journal of Psychiatric Research 43:1, pages 13-23.
Crossref
Crossref
John Cookson. (2018) Atypical antipsychotics in bipolar disorder: the treatment of mania. Advances in Psychiatric Treatment 14:5, pages 330-338.
Crossref
Crossref
Martha Sajatovic, Joseph R Calabrese & Jamie Mullen. (2008) Quetiapine for the treatment of bipolar mania in older adults. Bipolar Disorders 10:6, pages 662-671.
Crossref
Crossref
Charles Bowden, Ahmet Göğüş, Heinz Grunze, Lars Häggström, Janusz Rybakowski & Eduard Vieta. (2008) A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. International Clinical Psychopharmacology 23:5, pages 254-262.
Crossref
Crossref
Keming Gao, David E. Kemp, Stephen J. Ganocy, Prashant Gajwani, Guohua Xia & Joseph R. Calabrese. (2008) Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia. Journal of Clinical Psychopharmacology 28:2, pages 203-209.
Crossref
Crossref
Daniel F. ConnorThomas J. McLaughlinMary Jeffers-Terry. (2008) Randomized Controlled Pilot Study of Quetiapine in the Treatment of Adolescent Conduct Disorder. Journal of Child and Adolescent Psychopharmacology 18:2, pages 140-156.
Crossref
Crossref
Hans-Jürgen Möller, Sunny Johnson, Temenuzhka Mateva, Martin Brecher, Ola Svensson, Frank Miller & Didier Meulien. (2008) Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia. International Clinical Psychopharmacology 23:2, pages 95-105.
Crossref
Crossref
Helen R. WinterWillie R. EarleyJennifer E. Hamer-MaanssonPatty C. DavisMark A. Smith. (2008) Steady-State Pharmacokinetic, Safety, and Tolerability Profiles of Quetiapine, Norquetiapine, and Other Quetiapine Metabolites in Pediatric and Adult Patients with Psychotic Disorders. Journal of Child and Adolescent Psychopharmacology 18:1, pages 81-98.
Crossref
Crossref
Roger S. McIntyre. (2008) Validity of conclusions about quetiapine. American Journal of Health-System Pharmacy 65:2, pages 114-115.
Crossref
Crossref
Konstantinos N Fountoulakis, Eduard Vieta, Melina Siamouli, Marc Valenti, Stamatia Magiria, Timucin Oral, David Fresno, Panteleimon Giannakopoulos & George S Kaprinis. (2007) Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. Annals of General Psychiatry 6:1.
Crossref
Crossref
Helen R. Winter, C. Lindsay DeVane, Carlos Figueroa, Debra J. Ennis, Jennifer E. Hamer-Maansson, Patty C. Davis & Mark A. Smith. (2007) Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder. Human Psychopharmacology: Clinical and Experimental 22:7, pages 469-476.
Crossref
Crossref
Dajung J. Kim, In Kyoon Lyoo, Sujung J. Yoon, Taeyoung Choi, Byungchol Lee, Jieun E. Kim, Joonsun S. Lee & Perry F. Renshaw. (2007) Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:6, pages 1182-1188.
Crossref
Crossref
Gérard Emilien, Lucia Septien, Claudine Brisard, Emmanuelle Corruble & Michel Bourin. (2007) Bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:5, pages 975-996.
Crossref
Crossref
Lorenz Hilwerling, Georg Juckel & Stefan Georg Schröder. (2006) Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006. International Journal of Geriatric Psychiatry 22:5, pages 401-404.
Crossref
Crossref
Yasser Khazaal, Sophie Tapparel, Anne Chatton, Stephane Rothen, Martin Preisig & Daniele Zullino. (2007) Quetiapine dosage in bipolar disorder episodes and mixed states. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:3, pages 727-730.
Crossref
Crossref
Eduard Vieta, Joseph F. Goldberg, Jamie Mullen, M?rten V?ger?Bj?rn Paulsson. (2007) Quetiapine in the treatment of acute mania: Target dose for efficacious treatment. Journal of Affective Disorders 100, pages S23-S31.
Crossref
Crossref
Roger S. McIntyre, Jakub Z. Konarski, Martin Jones & Björn Paulsson. (2007) Quetiapine in the treatment of acute bipolar mania: Efficacy across a broad range of symptoms. Journal of Affective Disorders 100, pages S5-S14.
Crossref
Crossref
Peter F. Buckley, Björn Paulsson & Martin Brecher. (2007) Treatment of agitation and aggression in bipolar mania: Efficacy of quetiapine. Journal of Affective Disorders 100, pages S33-S43.
Crossref
Crossref
Caleb M. Adler, David E. Fleck, Martin Brecher & Stephen M. Strakowski. (2007) Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. Journal of Affective Disorders 100, pages S15-S22.
Crossref
Crossref
Michael E. Thase, Wayne Macfadden, Richard H. Weisler, William Chang, Björn Paulsson, Arifulla Khan & Joseph R. Calabrese. (2006) Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression. Journal of Clinical Psychopharmacology 26:6, pages 600-609.
Crossref
Crossref
Prashant Gajwani, David E. Kemp, David J. Muzina, Guohua Xia, Keming Gao & Joseph R. Calabrese. (2006) Acute treatment of mania: An update on new medications. Current Psychiatry Reports 8:6, pages 504-509.
Crossref
Crossref
T. Attarbaschi & S. Kasper. (2006) Behandlungsmöglichkeiten der akuten Manie mit atypischen AntipsychotikaTreatment options for bipolar mania. Der Nervenarzt 77:11, pages 1310-1322.
Crossref
Crossref
Henry A Nasrallah, Martin Brecher & Björn Paulsson. (2006) Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disorders 8:5p1, pages 467-474.
Crossref
Crossref
Moritz Mühlbacher, Christoph Egger & Christoph Stuppäck. (2006) Quetiapin zur Therapie manischer Phasen in der klinischen Praxis: Ergebnisse einer offenen, multizentrischen StudieQuetiapine in the treatment of mania in a naturalistic setting: Results of an open, multicenter study. Psychiatrie und Psychotherapie 2:2, pages 55-58.
Crossref
Crossref
A. Hatim, H. Habil, S. G. Jesjeet, C. C. Low, J. Joseph, S. T. Jambunathan & N. Z. Zuraida. (2006) Safety and efficacy of rapid dose administration of quetiapine in bipolar mania. Human Psychopharmacology: Clinical and Experimental 21:5, pages 313-318.
Crossref
Crossref
Christoph Born, Florian Seemüller & Heinz Grunze. (2006) Quetiapine: an approach for the treatment of bipolar disorders. Future Neurology 1:2, pages 131-138.
Crossref
Crossref
Armand Hausmann, Robert Strauss, Ulrike Weiss & Andreas Conca. (2005) Sind Antipsychotika der zweiten und dritten Generation auch Phasenprophylaktika?Are second and third generation antipsychotics moodstabilizers? A systematical analysis of the literature. Psychiatrie und Psychotherapie 1:2, pages 75-90.
Crossref
Crossref
Eduard Vieta. (2005) Mood stabilization in the treatment of bipolar disorder: focus on quetiapine. Human Psychopharmacology: Clinical and Experimental 20:4, pages 225-236.
Crossref
Crossref
Toni M Dando & Gillian M Keating. (2005) Quetiapine. Drugs 65:17, pages 2533-2551.
Crossref
Crossref